The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Enzymes involved in the bioconversion of ester-based prodrugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sussman, J. L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L., & Silman, I. (1991) · Science · doi:10.1126/science.1678899 · Cited by 2,707
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067589 · Cited by 1,390
Miwa, M., Ura, M., Nishida, M., Sawada, N., Ishikawa, T., Mori, K., Shimma, N., Umeda, I., & Ishitsuka, H. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00058-6 · Cited by 1,240
Molecular and cellular biology of cholinesterases
Massoulié, J., Pezzementi, L., Bon, S., Krejci, E., & Vallette, F.-M. (1993) · Progress in Neurobiology · doi:10.1016/0301-0082(93)90040-y · Cited by 1,214
Casarett & Doull's Toxicology: The Basic Science of Poisons
Klaassen, C. D. (1998) · Cited by 1,179
Acetylcholinesterase: Enzyme structure, reaction dynamics, and virtual transition states
Quinn, D. M. (1987) · Chemical Reviews · doi:10.1021/cr00081a005 · Cited by 1,072
Esterase Activities of Human Carbonic Anhydrases B and C
Verpoorte, J. A., Mehta, S., & Edsall, J. T. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)95800-x · Cited by 1,064
Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products
Nicolet, Y., Lockridge, O., Masson, P., Fontecilla-Camps, J. C., & Nachon, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210241200 · Cited by 840
Paraoxonase and Atherosclerosis
Durrington, P. N., Mackness, B., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.473 · Cited by 818
The Molecular Forms of Cholinesterase and Acetylcholinesterase in Vertebrates
Massoulie, J., & Bon, S. (1982) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.05.030182.000421 · Cited by 814
THE MAMMALIAN CARBOXYLESTERASES: From Molecules to Functions
Satoh, T., & Hosokawa, M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.257 · Cited by 758
Aldridge, W. N. (1953) · Biochemical Journal · doi:10.1042/bj0530110 · Cited by 741
The human serum paraoxonase/arylesterase polymorphism.
Eckerson, H. W., Wyte, C. M., & Du, B. N. L. (1983) · PubMed · Cited by 732
The Cholinesterases: From Genes to Proteins
Taylor, P., & Radic, Z. (1994) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001433 · Cited by 669
Harel, M., Aharoni, A., Gaidukov, L., Brumshtein, B., Khersonsky, O., Meged, R., Dvir, H., Ravelli, R. B. G., McCarthy, A., Toker, L., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb767 · Cited by 646
Drug Transfer and Metabolism by the Human Placenta
Syme, M. R., Paxton, J. W., & Keelan, J. A. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443080-00001 · Cited by 634
Sogorb, M. A., & Vilanova, E. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00543-4 · Cited by 564
Enzyme-Catalyzed Activation of Anticancer Prodrugs
Rooseboom, M., Commandeur, J. N. M., & Vermeulen, N. P. E. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.1.3 · Cited by 497
Human aldehyde dehydrogenase gene family
Yoshida, A., Rzhetsky, A., Hsu, L. C., & Chang, C. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510549.x · Cited by 476
Acetylcholinesterase in Alzheimer's disease
Talesa, V. N. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00309-8 · Cited by 450
Pharmacogenetics of paraoxonases: a brief review
Draganov, D. I., & Du, B. N. L. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0833-1 · Cited by 416
Chemical Aspects of Selective Toxicity
ALBERT, A. (1958) · Nature · doi:10.1038/182421a0 · Cited by 401
Lessons Learned from Marketed and Investigational Prodrugs
Ettmayer, P., Amidon, G. L., Clement, B., & Testa, B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0303812 · Cited by 384
Harel, M., Quinn, D. M., Nair, H. K., Silman, I., & Sussman, J. L. (1996) · Journal of the American Chemical Society · doi:10.1021/ja952232h · Cited by 369
Beaumont, K., Webster, R., Gardner, I., & Dack, K. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489253 · Cited by 363
Arendt, T., Brückner, M. K., Lange, M., & Bigl, V. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90189-x · Cited by 314
Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity
Vellom, D. C., Radic, Z., Li, Y., Pickering, N. A., Camp, S., & Taylor, P. (1993) · Biochemistry · doi:10.1021/bi00052a003 · Cited by 312
Enz, A., Amstutz, R., Boddeke, H., Gmelin, G., & Malanowski, J. (1993) · Progress in Brain Research · doi:10.1016/s0079-6123(08)62429-2 · Cited by 301
Aharoni, A., Gaidukov, L., Yagur, S., Toker, L., Silman, I., & Tawfik, D. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536901100 · Cited by 288
The Origin of the Molecular Diversity and Functional Anchoring of Cholinesterases
Massoulié, J. (2002) · Neurosignals · doi:10.1159/000065054 · Cited by 281
Strategies for enzyme/prodrug cancer therapy.
Xu, G., & McLeod, H. L. (2001) · PubMed · Cited by 279
Targeted prodrug design to optimize drug delivery
Han, H.-K., & Amidon, G. L. (2000) · AAPS PharmSci · doi:10.1208/ps020106 · Cited by 277
Hong, S. Y., Oh, J. E., & Lee, K.-H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00259-2 · Cited by 274
Costa, L. G., Cole, T. B., Jarvik, G. P., & Furlong, C. E. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152421 · Cited by 264
Lockridge, O. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90044-3 · Cited by 237
Carboxylesterases and Amidases
HEYMANN, E. (1980) · Enzymatic Basis of Detoxication · doi:10.1016/b978-0-12-380002-2.50022-1 · Cited by 229
Alternative Splicing and Neuritic mRNA Translocation Under Long-Term Neuronal Hypersensitivity
Meshorer, E., Erb, C., Gazit, R., Pavlovsky, L., Kaufer, D., Friedman, A., Glick, D., Ben-Arie, N., & Soreq, H. (2002) · Science · doi:10.1126/science.1066752 · Cited by 228
Drug Chirality and its Clinical Significance
Hutt, A. J., & Tan, S. C. (1996) · Drugs · doi:10.2165/00003495-199600525-00003 · Cited by 227
Li, W., Escarpe, P. A., Eisenberg, E. J., Cundy, K. C., Sweet, C., Jakeman, K. J., Merson, J., Lew, W., Williams, M., Zhang, L., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.647 · Cited by 223
SYNTHETIC AMINO ACIDS AND THE NATURE OF l‐DOPA TRANSPORT AT THE BLOOD‐BRAIN BARRIER
Wade, L. A., & Katzman, R. (1975) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1975.tb04415.x · Cited by 211
The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity
James, R. W., & Deakin, S. P. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.08.012 · Cited by 200
Brimijoin, S. (1983) · Progress in Neurobiology · doi:10.1016/0301-0082(83)90015-1 · Cited by 196
Atack, J. R., Perry, E. K., Bonham, J. R., Candy, J. M., & Perry, R. H. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb02858.x · Cited by 194
Apolipoprotein J Is Associated with Paraoxonase in Human Plasma
Kelso, G. J., Stuart, W. D., Richter, R. J., Furlong, C. E., Jordan-Starck, T. C., & Harmony, J. A. K. (1994) · Biochemistry · doi:10.1021/bi00169a026 · Cited by 179
Crystal Structure of Human Carboxylesterase 1 Complexed with the Alzheimer's Drug Tacrine
Bencharit, S., Morton, C. L., Hyatt, J. L., Kuhn, P., Danks, M. K., Potter, P. M., & Redinbo, M. R. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00071-1 · Cited by 174
SATOH, T., HOSOKAWA, M., ATSUMI, R., SUZUKI, W., HAKUSUI, H., & NAGAI, E. (1994) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.17.662 · Cited by 174
Moser, V (1998) · Toxicological Sciences · doi:10.1006/toxs.1998.2526 · Cited by 160
Paraoxonase and coronary heart disease
Mackness, M., Mackness, B., & Durrington, P. N. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)00046-6 · Cited by 158
Laeis, P., Püchler, K., & Kirch, W. (2001) · Journal of Hypertension · doi:10.1097/00004872-200106001-00004 · Cited by 156
Sanghani, S. P., Quinney, S. K., Fredenburg, T. B., Davis, W. I., Murry, D. J., & BOSRON, W. F. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.5.505 · Cited by 145
Sakurai, Y., Ma, S.-F., Watanabe, H., Yamaotsu, N., Hirono, S., Kurono, Y., Kragh‐Hansen, U., & Otagiri, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016241.84630.06 · Cited by 135
Structure and Function of Cholinesterases and Related Proteins
(1998) · Springer eBooks · doi:10.1007/978-1-4899-1540-5 · Cited by 132
Sklan, E. H., Lowenthal, A., Korner, M., Ritov, Y., Landers, D. M., Rankinen, T., Bouchard, C., Leon, A. S., Rice, T., Rao, D. C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307659101 · Cited by 130
Tumour Cytochrome P450 and Drug Activation
Patterson, L. H., & Murray, G. I. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394502 · Cited by 126
Rodrigo, L. S., Hernández, A. F., López-Caballero, J. J., Gil, F., & Pla, A. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(01)00225-3 · Cited by 125
Prodrug research: futile or fertile?
Testa, B. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.005 · Cited by 124
Prodrugs for Gene‐Directed Enzyme‐Prodrug Therapy (Suicide Gene Therapy)
Denny, W. A. (2003) · BioMed Research International · doi:10.1155/s1110724303209098 · Cited by 124
Role of Metabolism in Ocular Drug Delivery
Duvvuri, S., Majumdar, S., & Mitra, A. K. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335342 · Cited by 122
Majumdar, S., Duvvuri, S., & Mitra, A. K. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.006 · Cited by 114
Chirality: a blueprint for the future
Burke, D. L., & Henderson, D. J. (2002) · British Journal of Anaesthesia · doi:10.1093/bja/88.4.563 · Cited by 112
Expression and localization of acetylcholinesterase at the neuromuscular junction
Rotundo, R. L. (2003) · Journal of Neurocytology · doi:10.1023/b:neur.0000020621.58197.d4 · Cited by 103
Interindividual variation in carboxylesterase levels in human liver microsomes.
Hosokawa, M., Endo, T., Fujisawa, M., Hara, S., Iwata, N., Sato, Y. Z., & Satoh, T. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06743-1 · Cited by 103
Pharmacokinetics and its role in small molecule drug discovery research
Jang, G. R., Harris, R. Z., & Lau, D. T. (2001) · Medicinal Research Reviews · doi:10.1002/med.1015 · Cited by 100
Tougou, K., Nakamura, A., Watanabe, S., Okuyama, Y., & MORINO, A. (1998) · PubMed · Cited by 99
Possible Physiological Roles of Carboxylic Ester Hydrolases
Leinweber, F.-J. (1987) · Drug Metabolism Reviews · doi:10.3109/03602538708994129 · Cited by 99
Pharmacological Importance of Stereochemical Resolution of Enantiomeric Drugs
Islam, M. R., Mahdi, J. G., & Bowen, I. D. (1997) · Drug Safety · doi:10.2165/00002018-199717030-00002 · Cited by 98
Wadkins, R. M., Hyatt, J. L., Yoon, K. J. P., Morton, C. L., Lee, R. E., Jr., Damodaran, K., Beroza, P., Danks, M. K., & Potter, P. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1336 · Cited by 95
Allometric issues in drug development†
Mahmood, I. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9902163 · Cited by 92
Morton, C. L., Wadkins, R. M., Danks, M. K., & Potter, P. M. (1999) · PubMed · Cited by 91
Expression of cytochrome P450 in tumor tissues and its association with cancer development
Oyama, T. (2004) · Frontiers in bioscience · doi:10.2741/1378 · Cited by 89
Soriano, F. G. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.5.647 · Cited by 80
Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid.
Salvi, A., Carrupt, P., Mayer, J. M., & Testa, B. (1997) · PubMed · Cited by 78
MULLER, F. M., Dumez, Y., & Massoulié, J. (1985) · Brain Research · doi:10.1016/0006-8993(85)91555-0 · Cited by 76
Regulation of cytochrome P450 gene expression in the olfactory mucosa
Ling, G., Gu, J., Genter, M. B., Zhuo, X., & Ding, X. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.02.003 · Cited by 75
Buchwald, P., & Bodor, N. S. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990145k · Cited by 73
Acetylcholinesterase: C-terminal domains, molecular forms and functional localization
Massoulié, J., Anselmet, A., Bon, S., Krejci, É., Legay, C., Morel, N., & Simon, S. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80007-7 · Cited by 73
Molecular aspects of carboxylesterase isoforms in comparison with other esterases
Satoh, T., & Hosokawa, M. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03493-5 · Cited by 72
Liu, P., Wang, Y., Ewis, H. E., Abdelal, A. T. H., Lu, C., Harrison, R. W., & Weber, I. T. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.069 · Cited by 71
Synthesis of New Carboxylesterase Inhibitors and Evaluation of Potency and Water Solubility
Wheelock, C. E., Severson, T. F., & Hammock, B. D. (2001) · Chemical Research in Toxicology · doi:10.1021/tx015508+ · Cited by 65
Molecular forms of acetylcholinesterases in Alzheimer's disease.
Sg, Y., Goodridge, B., Katz, J., Lockett, G., Nafziger, D., Usiak, M., & Younkin, L. H. (1986) · PubMed · Cited by 63
Pharmacogenetics of Drug Metabolism
Desta, Z., & Flockhart, D. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802101-9.00018-1 · Cited by 62
Wadkins, R. M., Morton, C. L., Weeks, J. K., Oliver, L., Wierdl, M., Danks, M. K., & Potter, P. M. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.2.355 · Cited by 61
Tak, R. V., Pal, D., Gao, H., Dey, S., & Mitra, A. K. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1101 · Cited by 60
Jasmin, B. J., & Gisiger, V. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-05-01444.1990 · Cited by 56
Human liver paraoxonase (PON1): Subcellular distribution and characterization
Gonzalvo, M. C., Gil, F., Hernández, A. F., Rodrigo, L. S., Villanueva, E., & Pla, A. (1998) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/(sici)1099-0461(1998)12:1<61::aid-jbt8>3.0.co;2-n · Cited by 52
Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil
Brass, E. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(02)17636-3 · Cited by 50
Prodrug strategies to enhance the intestinal absorption of peptides
Gangwar, S., Pauletti, G. M., Wang, B., Siahaan, T. J., Stella, V. J., & Borchardt, R. T. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01011-8 · Cited by 50
Self-citationNakanishi, M., Takanami, Y., Maruyama, T., Murata, M., Motohashi, Y., Nakano, S., Uchida, K., Maruyama, C., Kyotani, S., & Tsushima, M. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.337 · Cited by 43
Critique of Prospective Allometric Scaling: Does the Emperor Have Clothes?
Bonate, P. L., & Howard, D. R. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022009017 · Cited by 43
Enzyme-Prodrug Strategies for Cancer Therapy
Melton, R. G., & Knox, R. J. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4823-2 · Cited by 40
Prospective Allometric Scaling: Does the Emperor Have Clothes?
Bonate, P. L., & Howard, D. R. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/009127000004000601 · Cited by 36
Gene directed enzyme prodrug therapy for cancer
McNeish, I. A., Searle, P. F., Young, L. S., & Kerr, D. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00033-1 · Cited by 35
What are the Treatment Options for Patients with Severe Alzheimer???s Disease?
Voisin, T., Reynish, E. L., Portet, F., Feldman, H., & Vellas, B. J. (2004) · CNS Drugs · doi:10.2165/00023210-200418090-00003 · Cited by 29
Gisiger, V., Sheker, S., & Gardiner, P. F. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80133-n · Cited by 21
Oosterhoff, D., Witlox, A. M. A., van Beusechem, V. W., Haisma, H. J., Schaap, G. R., Bras, J., Kruyt, F. A. E., Molenaar, B., Boven, E., Wuisman, P. I. J. M., et al. (2003) · PubMed · Cited by 20
Acetyl‐ and butyrylcholinesterase activities in the rat retina and retinal pigment epithelium
Sánchez‐Chávez, G., Vidal, C. J., & Salceda, R. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410512 · Cited by 14
Suicide gene therapy : methods and reviews
Springer, C. J. (2004) · Medical Entomology and Zoology · Cited by 13
Berninsone, P. M., Katz, E., Napp, M., & Azcurra, J. M. (1989) · Biochemistry and Cell Biology · doi:10.1139/o89-121 · Cited by 12
Diversity and Processing of Acetylcholinesterase
Massoulié, J., Anselmet, A., Bon, S., Krejci, É., Legay, C., Mayat, E., Morel, N., & Simon, S. (1998) · Springer eBooks · doi:10.1007/978-1-4899-1540-5_2 · Cited by 11
Enzyme-Prodrug Systems: Carboxylesterase/CPT-11
Danks, M. K., & Potter, P. M. (2004) · Humana Press eBooks · doi:10.1385/1-59259-429-8:247 · Cited by 10
Decrease in membrane-bound G4 form of acetylcholinesterase in postmortem Alzheimer brain.
Schegg, K. M., Nielsen, S. L., Zweig, R. M., & Peacock, J. H. (1989) · PubMed · Cited by 9
Cited by
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Prodrugs—from Serendipity to Rational Design
Huttunen, K. M., Raunio, H., & Rautio, J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003459 · Cited by 505
Prodrugs of Phosphates and Phosphonates
Hecker, S. J., & Erion, M. D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701260b · Cited by 414
Cheetham, A. G., Chakroun, R. W., Ma, W., & Cui, H. (2017) · Chem. Soc. Rev. · doi:10.1039/c7cs00521k · Cited by 367
Prodrugs for improving tumor targetability and efficiency
Mahato, R., Tai, W., & Cheng, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.002 · Cited by 353
Metadata
- Authors
- Liederer, B. M., & Borchardt, R. T.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 95
- Issue
- 6
- Pages
- 1177-1195
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2059142487
- Cited by
- 377
- References
- 101
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.